Huynh Le Maux, A.; Pignol, B.; Behr-Roussel, D.; Blachon, J.-L.; Chabrier, P.-E.; Compagnie, S.; Picaut, P.; Bernabé, J.; Giuliano, F.; Denys, P.
Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity? Toxins 2015, 7, 5462-5471.
https://doi.org/10.3390/toxins7124896
AMA Style
Huynh Le Maux A, Pignol B, Behr-Roussel D, Blachon J-L, Chabrier P-E, Compagnie S, Picaut P, Bernabé J, Giuliano F, Denys P.
Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity? Toxins. 2015; 7(12):5462-5471.
https://doi.org/10.3390/toxins7124896
Chicago/Turabian Style
Huynh Le Maux, Amélie, Bernadette Pignol, Delphine Behr-Roussel, Jean-Luc Blachon, Pierre-Etienne Chabrier, Sandrine Compagnie, Philippe Picaut, Jacques Bernabé, François Giuliano, and Pierre Denys.
2015. "Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?" Toxins 7, no. 12: 5462-5471.
https://doi.org/10.3390/toxins7124896
APA Style
Huynh Le Maux, A., Pignol, B., Behr-Roussel, D., Blachon, J.-L., Chabrier, P.-E., Compagnie, S., Picaut, P., Bernabé, J., Giuliano, F., & Denys, P.
(2015). Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity? Toxins, 7(12), 5462-5471.
https://doi.org/10.3390/toxins7124896
